Location History:
- Ashburn, VA (US) (2010 - 2023)
- Lenoir, NC (US) (2018 - 2024)
- Waxhaw, NC (US) (2019 - 2024)
Company Filing History:
21 out of 21 
5 out of 5 
4 out of 5 Years Active: 2010-2025
Title: Phanesh B Koneru: Innovator in Pharmaceutical Compositions
Introduction
Phanesh B Koneru, based in Ashburn, Virginia, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a remarkable portfolio of 33 patents, his work reflects a commitment to improving healthcare delivery and patient outcomes.
Latest Patents
Among his latest inventions, Koneru has developed a patent for "Stable, highly pure L-cysteine compositions for injection and methods of use." This patent outlines a formulation comprising L-cysteine or a pharmaceutically acceptable salt or hydrate thereof, designed for parenteral administration. The composition includes precise measurements of aluminum, cystine, pyruvic acid, and a pharmaceutically acceptable carrier, primarily water, ensuring stability and purity. Additionally, the composition is enclosed in single-use containers of varying volumes, making it suitable for diverse medical applications, including total parenteral nutrition.
Career Highlights
Throughout his career, Phanesh B Koneru has collaborated with notable pharmaceutical companies, including Exela Pharma Sciences, LLC and Exela Holdings, Inc. His extensive experience in these organizations has greatly contributed to his inventive output and expertise.
Collaborations
Koneru has worked alongside talented individuals such as John Maloney and Aruna Koganti. These collaborations have fostered an environment of creativity and innovation, further enhancing the development of his groundbreaking pharmaceutical compositions.
Conclusion
Phanesh B Koneru's dedication to innovation in the pharmaceutical industry is evident through his numerous patents and collaborative efforts. His work is poised to make a lasting impact on therapeutic practices, particularly in the formulation of stable and effective injectable compositions. As he continues to push the boundaries of pharmaceutical science, the implications of his inventions will undoubtedly benefit patients and healthcare professionals alike.